Amphastar Pharmaceuticals Inc vs Manchester United PLC — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Manchester United PLC trades at $22.23 (market cap $3.80B). The key difference: Manchester United PLC is far larger — about 4.4× Amphastar Pharmaceuticals Inc's market cap, and Manchester United PLC pays a 1.26% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | MANU | |
|---|---|---|
Market Cap | $868.62M | $3.80B |
Sector | Health | Media |
52-Week High | $30.81 | $23.53 |
52-Week Low | $16.87 | $15.10 |
Enterprise Value | $1.27B | $4.74B |
Dividend Yield | — | 1.26% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →